Aradigm Co. (NASDAQ:ARDM)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.17. Aradigm shares last traded at $0.17, with a volume of 1,000 shares trading hands.
The company has a market capitalization of $2.51 million, a price-to-earnings ratio of -0.23 and a beta of 1.57. The business’s 50 day moving average is $0.18.
About Aradigm (NASDAQ:ARDM)
Aradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. Its lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq and Lipoquin that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis, cystic fibrosis, and non-tuberculosis mycobacterium.
Receive News & Ratings for Aradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aradigm and related companies with MarketBeat.com's FREE daily email newsletter.